| 000 | 01026nam a2200277 a 4500 | ||
|---|---|---|---|
| 005 | 20250918151354.0 | ||
| 008 | 120320s2011 njua 001 0 eng | ||
| 020 |
_a9780470343425 _cRM360.24 |
||
| 039 | 9 |
_a201205231551 _bshafiq _c201205231548 _dshafiq _c201205071501 _dIzzati _y03-20-2012 _zbalqis |
|
| 040 | _dUKM | ||
| 090 | _aWK820.M5871 2011 9HUKM | ||
| 090 |
_aWK820 _b.M5871 2011 9HUKM |
||
| 245 | 0 | 0 |
_aMetabolic syndrome : _bunderlying mechanisms and drug therapies / _cedited by Minghan Wang. |
| 260 |
_aHoboken : _bJohn Wiley & Sons, _c2011. |
||
| 300 |
_axiii, 494 p. : _bill. ; _c24 cm. |
||
| 650 | 2 |
_aMetabolic Syndrome X _xphysiopathology. |
|
| 650 | 2 |
_aMetabolic Syndrome X _xdrug therapy. |
|
| 700 | 1 | _aWang, Minghan. | |
| 907 |
_a.b15280809 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWK820.M5871 2011 9HUKM |
||
| 914 | _avtls003491848 | ||
| 990 | _aNHR/shafiq | ||
| 991 | _aJabatan Institut Perubatan Molekul (UMBI), PPUKM | ||
| 998 |
_ah _b2012-07-03 _cm _da _feng _gnju _y0 _z.b15280809 |
||
| 999 |
_c511986 _d511986 |
||